Unknown

Dataset Information

0

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections.

ABSTRACT: Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for Mycobacterium abscessus. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2-11.0) months. Clinical success occurred in 9/12 (75.0%) patients. Three patients experienced a possible adverse effect while on therapy.

SUBMITTER: Morrisette T 

PROVIDER: S-EPMC7890947 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for <i>Mycobacterium abscessus</i>. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2-11.0) months. Clinical success occurred in 9/12 (75.0%) patients. Three patients experienced a possible adverse effect while on therapy. ...[more]

Similar Datasets

Unknown Omadacycline Potentiates Clarithromycin Activity Against <i>Mycobacterium abscessus</i>.
| S-EPMC8693020 | biostudies-literature
Unknown Long-term Safety and Tolerability of Omadacycline for the Treatment of <i>Mycobacterium abscessus</i> Infections.
| S-EPMC10354853 | biostudies-literature
Unknown Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes.
| S-EPMC10583686 | biostudies-literature
Unknown Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity <i>In Vitro</i>.
| S-EPMC10269442 | biostudies-literature
Unknown Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections.
| S-EPMC4054987 | biostudies-literature
Unknown Evaluation of omadacycline against intracellular <i>Mycobacterium abscessus</i> in an infection model in human macrophages.
| S-EPMC10502775 | biostudies-literature
Unknown Alternative and Experimental Therapies of Mycobacterium abscessus Infections.
| S-EPMC7555341 | biostudies-literature
Unknown Mycobacterium abscessus Prosthetic Joint Infections of the Knee.
| S-EPMC6831809 | biostudies-literature
Transcriptomics Spectinomycin Analogs for the Treatment of Mycobacterium abscessus Infections
2023-01-09 | GSE222081 | GEO
Unknown Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.
| S-EPMC6248177 | biostudies-literature